1Holman, H, Lorig, K. Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care. BMJ 2000; 320(7234): 526–7.
2Department of Health. The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century. Department of Health, London, 2001.
3Patel, SR, Bakken, S, Ruland, C. Recent advances in shared decision making for mental health. Curr Opin Psychiatry 2008; 21(6): 606–12.
4Charles, C, Gafni, A, Whelan, T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997; 44(5): 681–92.
5Slade, M. Implementing shared decision making in routine mental health care. World Psychiatry 2017; 16(2): 146–53.
6Department of Health. Liberating the NHS: No Decision About Me, Without Me– Government Response to the Consultation. Department of Health London, 2012.
7Frosch, DL, Moulton, BW, Wexler, RM, Holmes-Rovner, M, Volk, RJ, Levin, CA. Shared decision making in the United States: policy and implementation activity on multiple fronts. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2011; 105(4): 305–12.
8Gray, R, Rofail, D, Allen, J, Newey, T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J Adv Nurs 2005; 52(1): 31–7.
9Harris, K, Brooks, H, Lythgoe, G, Bee, P, Lovell, K, Drake, RJ. Exploring service users’, carers’ and professionals’ perspectives and experiences of current antipsychotic prescribing: a qualitative study. Chronic Illn 2017; 13(4): 275–87.
10Adams, JR, Drake, RE, Wolford, GL. Shared decision-making preferences of people with severe mental illness. Psychiatr Serv 2007; 58(9): 1219–21.
11Morant, N, Kaminskiy, E, Ramon, S. Shared decision making for psychiatric medication management: beyond the micro-social. Health Expect 2016; 19(5): 1002–14.
12Hamann, J, Leucht, S, Kissling, W. Shared decision making in psychiatry. (0001-690X (Print)).
13National Institute for Clinical Excellence. Psychosis and Schizophrenia in Adults: Prevention and Management. National Clinical Practice Guidelines Number CG178: NICE, 2014.
14Leucht, S, Cipriani, A, Spineli, L, Mavridis, D, Örey, D, Richter, F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382(9896): 951–62.
15Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353(12): 1209–23.
16Jones, PB, Barnes, TE, Davies, L, Dunn, G, Lloyd, H, Hayhurst, KP, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 2006; 63(10): 1079–87.
17Tiihonen, J, Walhbeck, K, Lönnqvist, J, Klaukka, T, Ioannidis, JPA, Volavka, J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006; 333(7561): 224.
18Muench, J, Hamer, AM. Adverse effects of antipsychotic medications. Am Fam Physician 2010; 81(5): 617–22.
19Duncan, E, Best, C, Hagen, S. Shared decision making interventions for people with mental health conditions. Cochrane Database Syst Rev 2010; 2010(1): CD007297.
20Mahone, IH, Farrell, S, Hinton, I, Johnson, R, Moody, D, Rifkin, K, et al. Shared decision making in mental health treatment: qualitative findings from stakeholder focus groups. Arch Psychiatr Nurs 2011; 25(6): e27–36.
21Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. In: The Cochrane Collaboration (eds J Higgins, S Green): 2011.
22Tong, A, Sainsbury, P, Craig, J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19(6): 349–57.
23Mays, N, Pope, C. Assessing quality in qualitative research. BMJ 2000; 320(7226): 50.
24Thomas, J, Harden, A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 2008; 8(1): 45.
25Barnett-Page, E, Thomas, J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol 2009; 9(1): 59.
26Britten, N, Campbell, R, Pope, C, Donovan, J, Morgan, M, Pill, R. Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy 2002; 7(4): 209–15.
27Besenius, C, Bradley, E, Nolan, P. Attitudes of psychiatrists, nurses and service users towards prescribing and administrating depot antipsychotic medication. J Ment Health Train Educ Pract 2012; 7(1): 9–19.
28Carrick, R, Mitchell, A, Powell, RA, Lloyd, K. The quest for well-being: a qualitative study of the experience of taking antipsychotic medication. Psychol Psychother 2004; 77(1): 19–33.
29Chafetz, L. The experience of severe mental illness: a life history approach. Arch Psychiatr Nurs 1996; 10(1): 24–31.
30Chaplin, R, Lelliott, P, Quirk, A, Seale, C. Negotiating styles adopted by consultant psychiatrists when prescribing antipsychotics. Adv Psychiatr Treat 2007; 13(1): 43–50.
31Deegan, PE, Rapp, C, Holter, M, Riefer, M. A program to support shared decision making in an outpatient psychiatric medication clinic. Psychiatr Serv 2008; 59(6): 603–5.
32Delman, J, Clark, JA, Eisen, SV, Parker, VA. Facilitators and barriers to the active participation of clients with serious mental illnesses in medication decision making: the perceptions of young adult clients. J Behav Health Serv Res 2014; 42(2): 238–53.
33Deslandes, RE, John, DN, Deslandes, PN. An exploratory study of the patient experience of pharmacist supplementary prescribing in a secondary care mental health setting. Pharm Pract (Granada) 2015; 13(2): 553.
34El-Mallakh, P, Howard, PB, Bond, GR, Roque, AP. Challenges of implementing a medication management evidence-based practice in a community mental health setting: results of a qualitative study. Issues Ment Health Nurs 2014; 35(7): 517–25.
35Forchuk, C, Jewell, J, Tweedell, D, Steinnagel, L. Role changes experienced by clinical staff in relation to clients’ recovery from psychosis. J Psychiatr Ment Health Nurs 2003; 10(3): 269–76.
36Francis, SA, Patel, M. Caring for people with schizophrenia: family carers’ involvement with medication. Int J Pharm Pract 2000; 8(4): 314–23.
37Gibson, S, Brand, SL, Burt, S, Boden, ZV, Benson, O. Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. BMC Psychiatry 2013; 13: 153.
38Goscha, R, Rapp, C. Exploring the experiences of client involvement in medication decisions using a shared decision making model: results of a qualitative study. Community Ment Health J 2015; 51: 267–74.
39Green, CA, Polen, MR, Janoff, SL, Castleton, DK, Wisdom, JP, Vuckovic, N, et al. Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results. Psychiatr Rehabil J 2008; 32(1): 9–22.
40Hagen, BF, Nixen, G, Peters, T. The greater of two evils? How people with transformative psychotic experiences view psychotropic medications. Ethical Hum Psychol Psychiatry 2010; 12(1): 44–59.
41Hon, A. Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: findings from a grounded theory study. J Psychiatr Ment Health Nurs 2012; 19(4): 354–61.
42Iyer, S, Banks, N, Roy, M-A, Tibbo, P, Williams, R, Manchanda, R, et al. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part I-patient perspectives. Can J Psychiatry 2013; 58(5 suppl, 1): 14s–22s.
43Lacasse, JR, Hayes Piel, M, Lietz, CA, Rider, A, Hess, JZ. The client experience of psychiatric medication: a qualitative study. Soc Work Ment Health 2016; 14(1): 61–81.
44Lester, H, Tait, L, England, E, Tritter, J. Patient involvement in primary care mental health: a focus group study. Br J Gen Pract 2006; 56(527): 415–22.
45Lorem, GF, Frafjord, JS, Steffensen, M, Wang, CE. Medication and participation: a qualitative study of patient experiences with antipsychotic drugs. Nurs Ethics 2014; 21(3): 347–58.
46Malik, A, Das, AK. A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections. Ther Adv Psychopharmacol 2014; 4(5): 179–85.
47Martean, L, Evans, C. Prescribing for personality disorder: qualitative study of interviews with general and forensic consultant psychiatrists. Psychiatr Bull 2014; 38(3): 116–21.
48Mikesell, L, Bromley, E, Young, AS, Vona, P, Zima, B. Integrating client and clinician perspectives on psychotropic medication decisions: Developing a Communication-centered Epistemic Model of Shared Decision Making for mental health contexts. Health Commun 2016; 31(6): 707–17.
49Rogers, A, Day, J, Randall, F, Bentall, RP. Patients’ understanding and participation in a trial designed to improve the management of anti-psychotic medication - a qualitative study. Soc Psychiatry Psychiatr Epidemiol 2003; 38(12): 720–7.
50Sajatovic, M, Davies, M, Bauer, MS, McBride, L, Hays, RW, Safavi, R, et al. Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder. Compr Psychiatry 2005; 46: 272–7.
51Seale, C, Chaplin, R, Lelliott, P, Quirk, A. Sharing decisions in consultations involving anti-psychotic medication: a qualitative study of psychiatrists’ experiences. Soc Sci Med 2006; 62(11): 2861–73.
52Shepherd, A, Shorthouse, O, Gask, L. Consultant psychiatrists’ experiences of and attitudes towards shared decision making in antipsychotic prescribing, a qualitative study. BMC Psychiatry 2014; 14(1): 127.
53Stewart, DC, Anthony, GB, Chesson, R. ‘It's not my job. I'm the patient not the doctor’: patient perspectives on medicines management in the treatment of schizophrenia. Patient Educ Couns 2010; 78(2): 212–7.
54Svedberg, B, Lutzen, K. Psychiatric nurses’ attitudes towards patient autonomy in depot clinics. J Adv Nurs 2001; 35(4): 607–15.
55Tranulis, C, Goff, D, Henderson, DC, Freudenreich, O. Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients. Psychiatr Serv 2011; 62(8): 888–92.
56Rycroft-Malone, J. The PARIHS framework – a framework for guiding the implementation of evidence-based practice. J Nurs Care Qual 2004; 19(4): 297–304.
57Protheroe, J, Brooks, H, Chew-Graham, C, Gardner, C, Rogers, A. ‘Permission to participate?’ A qualitative study of participation in patients from differing socio-economic backgrounds. J Health Psychol 2013; 18(8): 1046–55.
58Nimmon, L, Stenfors-Hayes, T. The “Handling” of power in the physician-patient encounter: perceptions from experienced physicians. BMC Med Educ 2016; 16(1): 114.
59Stacey, D, Légaré, F, Lewis, K, Barry, MJ, Bennett, CL, Eden, KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017; 2017(4): CD001431.